Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Francisca Alcayaga-Miranda
Minimal RB-responsive E1A Promoter Modification to Attain Potency, Selectivity, and Transgene-Arming Capacity in Oncolytic Adenoviruses
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Related publications
Selectivity and Efficiency of Late Transgene Expression by Transcriptionally Targeted Oncolytic Adenoviruses Are Dependent on the Transgene Insertion Strategy
Human Gene Therapy
Molecular Medicine
Genetics
Molecular Biology
Effect of Transgene Location, Transcriptional Control Elements and Transgene Features in Armed Oncolytic Adenoviruses
Cancers
Cancer Research
Oncology
Armed Therapeutic Viruses: Strategies and Challenges to Arming Oncolytic Viruses With Therapeutic Genes
Cancer Gene Therapy
Cancer Research
Molecular Medicine
Molecular Biology
Improved Potency and Selectivity of an Oncolytic E1ACR2 and E1B19K Deleted Adenoviral Mutant in Prostate and Pancreatic Cancers
Clinical Cancer Research
Cancer Research
Oncology
Dual Promoter-Controlled Oncolytic Adenovirus CG5757 Has Strong Tumor Selectivity and Significant Antitumor Efficacy in Preclinical Models
Clinical Cancer Research
Cancer Research
Oncology
Oncolytic Potency and Reduced Virus Tumor-Specificity in Oncolytic Virotherapy. A Mathematical Modelling Approach
PLoS ONE
Multidisciplinary
Development of an Oncolytic Herpes Simplex Virus Using a Tumor-Specific HIF-responsive Promoter
Cancer Gene Therapy
Cancer Research
Molecular Medicine
Molecular Biology
117 “Arming” the Chimeric Oncolytic Adenovirus Enadenotucirev to Deliver Checkpoint Inhibitors and Other Therapeutics Directly to Tumours
European Journal of Cancer
Cancer Research
Oncology
Going Viral: A Review of Replication-Selective Oncolytic Adenoviruses
Oncotarget
Oncology
